Connect with us
Canada faces a severe cannabis oversupply, with 53.7 million unsold products as of December 2023. Despite legalization in 2018 and initial shortages, the market now struggles...
Due to ongoing medical cannabis shortages, Luxembourg plans to launch a tender for a new supplier later this year. Production bottlenecks caused two out of three...
Tetra Pharm Technologies and Kvantify, both Copenhagen-based companies, are partnering to revolutionize drug discovery targeting the endocannabinoid system (ECS). This alliance aims to accelerate drug development,...
South Africa's President Cyril Ramaphosa signed the Cannabis for Private Purposes Act, legalizing marijuana possession and cultivation for adults. The bill allows personal use, with limits...
The upcoming referendum in Slovenia on the legalization of marijuana may be a key moment for the future of drug policy in Europe. Legalization would bring...
Ukraine's government has removed hemp, cannabis resin, extracts, tinctures, and THC from its list of dangerous drugs. Effective August 16, 2024, these substances can be used...
Cannabis clubs, set to operate from July 1, must store member data, raising privacy concerns. The Cannabis Act mandates recording personal details and purchase information, which...
The DEA announced it will move cannabis from Schedule 1 to Schedule 3, acknowledging its medical uses and lower abuse potential. This reclassification boosts the commercial...
President Joe Biden announced the reclassification of cannabis from Schedule I to Schedule III under federal law, following an extensive review. This historic decision acknowledges cannabis's...
Minnesota, one of the newest states to legalize recreational cannabis, has expunged tens of thousands of minor cannabis-related convictions just nine months after the law's enactment....